One decade of 'Bench-to-Bedside' peptide receptor radionuclide therapy with indigenous [ ¹⁷⁷ Lu]Lu-DOTATATE obtained through 'Direct' neutron activation route: lessons learnt including practice evolution in an Indian setting.

Autor: Basu S; Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe Parel, Mumbai, India.; Homi Bhabha National Institute Mumbai, India., Chakraborty S; Homi Bhabha National Institute Mumbai, India.; Radiopharmaceuticals Division, BARC Mumbai, India., Parghane RV; Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe Parel, Mumbai, India.; Homi Bhabha National Institute Mumbai, India., Kamaldeep; Homi Bhabha National Institute Mumbai, India.; Health Physics Division, Bhabha Atomic Research Centre Mumbai, India., Ranade R; Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe Parel, Mumbai, India.; Homi Bhabha National Institute Mumbai, India., Thapa P; Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe Parel, Mumbai, India.; Homi Bhabha National Institute Mumbai, India., Asopa RV; Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe Parel, Mumbai, India.; Homi Bhabha National Institute Mumbai, India., Sonawane G; Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe Parel, Mumbai, India.; Homi Bhabha National Institute Mumbai, India., Nabar S; Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe Parel, Mumbai, India.; Homi Bhabha National Institute Mumbai, India., Shimpi H; Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe Parel, Mumbai, India.; Homi Bhabha National Institute Mumbai, India., Chandak A; Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe Parel, Mumbai, India.; Homi Bhabha National Institute Mumbai, India., Vimalnath KV; Radiopharmaceuticals Division, BARC Mumbai, India., Ostwal V; Homi Bhabha National Institute Mumbai, India.; Department of Medical Oncology, Tata Memorial Centre Mumbai, Maharashtra, India., Ramaswamy A; Homi Bhabha National Institute Mumbai, India.; Department of Medical Oncology, Tata Memorial Centre Mumbai, Maharashtra, India., Bhandare M; Homi Bhabha National Institute Mumbai, India.; Department of Surgical Oncology, Gastrointestinal and Hepato-Pancreato-Biliary Service, Tata Memorial Hospital Mumbai, India., Chaudhari V; Homi Bhabha National Institute Mumbai, India.; Department of Surgical Oncology, Gastrointestinal and Hepato-Pancreato-Biliary Service, Tata Memorial Hospital Mumbai, India., Shrikhande SV; Homi Bhabha National Institute Mumbai, India.; Department of Surgical Oncology, Gastrointestinal and Hepato-Pancreato-Biliary Service, Tata Memorial Hospital Mumbai, India., Sirohi B; Department of Medical Oncology, Tata Memorial Centre Mumbai, Maharashtra, India.; Apollo Proton Cancer Centre Chennai, India., Dash A; Homi Bhabha National Institute Mumbai, India.; Radiopharmaceuticals Division, BARC Mumbai, India., Banerjee S; Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe Parel, Mumbai, India.; Homi Bhabha National Institute Mumbai, India.

Publikováno v: American journal of nuclear medicine and molecular imaging [Am J Nucl Med Mol Imaging] 2020 Aug 25; Vol. 10 (4), pp. 178-211. Date of Electronic Publication: 2020 Aug 25 (Print Publication: 2020).

Liquid Chromatography ICP-MS to Assess the Stability of 175 Lu- and nat Ga-Based Tumor-Targeting Agents towards the Development of 177 Lu- and 68 Ga-Labeled Radiopharmaceuticals.

Autor: Wallimann, Rahel H.^1,2 (AUTHOR) cristina.mueller@psi.ch, Hensinger, Heloïse¹ (AUTHOR) heloise.hensinger@novartis.com, Müller, Cristina^2,3 (AUTHOR) roger.schibli@psi.ch, Schibli, Roger^2,3 (AUTHOR), Kneuer, Rainer¹ (AUTHOR) rainer.kneuer@novartis.com, Schindler, Patrick¹ (AUTHOR) patrick.schindler@novartis.com

Publikováno v: Pharmaceutics. Mar2024, Vol. 16 Issue 3, p299. 13p.

Evaluation of ⁹⁹Tc^m-labelled human immunoglobulin in animal models of experimentally induced inflammatory lesions.

Autor: SHIMPI, H. H., NORONHA, O. P. D., SAMUEL, A. M.

Publikováno v: Nuclear Medicine Communications; Oct1995, Vol. 16 Issue 10, p846-852, 7p

Gratifying clinical experience with an indigenously formulated single-vial lyophilized HYNIC-TOC kit at the radiopharmaceutical division of BARC: a pivotal boost for building up a peptide receptor radionuclide therapy programme in an Indian setting.

Autor: Basu S; Radiation Medicine Centre (B.A.R.C), Tata Memorial Centre Annexe, Jerbai Wadia Road, Parel, Mumbai, 400012, India, drsanb@yahoo.com., Kand P, Mallia M, Korde A, Shimpi H

Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2013 Oct; Vol. 40 (10), pp. 1622-4. Date of Electronic Publication: 2013 Jul 16.

Evaluation of 99Tcm-labelled human immunoglobulin in animal models of experimentally induced inflammatory lesions

Autor: SHIMPI, H. H., NORONHA, O. P. D., SAMUEL, A. M.

Publikováno v: Nuclear Medicine Communications; October 1995, Vol. 16 Issue: 10 p846-852, 7p